CONTACT US   |  (864) 397-5101

Ribbon Cutting Celebration Marks Nephron Donation of Critical Mission Van to Red Cross

Nephron Pharmaceuticals Corporation announced the donation of a Dodge Promaster 3500 to the American Red Cross of South Carolina on Wednesday.

The donation of the vehicle will provide critical assistance with disaster response and the processing of life-saving blood donations.

“I am honored to be a part of this effort that includes providing critical disaster relief to families and collecting and delivering blood to those in need across the state,” said Lou Kennedy, CEO of Nephron Pharmaceuticals, and member of the board of directors for Red Cross of the Lowcountry, who also serves as the Biomed Committee chair.

These vehicles are important to the Red Cross mission to collect, test, and deliver blood to patients. Vans like these are essential in disaster situations, enabling the Red Cross to lift up families impacted by everything from fires to hurricanes. 

The announcement was made at the Nephron headquarters, where Lou Kennedy and Rod Tolbert, CEO of American Red Cross of South Carolina, held a ribbon-cutting to commemorate the delivery of the new van. 

“Nephron Pharmaceuticals and their CEO Lou Kennedy have been such great partners to the American Red Cross. We simply cannot and will not be able to deliver our mission across our great state without partners and supporters like Lou and Nephron Pharmaceuticals,” said Rod Tolbert.

In addition to Kennedy and Tolbert, Brenda Green participated in the event, thanking the Red Cross and its leadership for the work the Red Cross does to assist children like her son, who has sickle cell anemia. World Sickle Cell Day is June 19.

“We thank you, Lou,” said Green. “We thank you for this opportunity. I think I can say on behalf of all of the parents and all of the caregivers of those with sickle cell that we appreciate you and your efforts. You are helping to save lives.”


Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.